Trade Genprex, Inc. - GNPX CFD

Add to favourite

0.3400

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.0073

Long position overnight fee

-0.023624%

Short position overnight fee

0.001401%

Overnight fee time

21:00 (UTC)

Min traded quantity

0.01

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	0.3299
Open	0.3027
1-Year Change	-89.11%
Day's Range	0.2865 - 0.3675

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 2, 2025	0.3299	0.0919	38.61%	0.2380	0.3805	0.2380
Apr 1, 2025	0.2198	-0.0232	-9.55%	0.2430	0.2521	0.2198
Mar 31, 2025	0.2432	-0.0097	-3.84%	0.2529	0.2531	0.2222
Mar 28, 2025	0.2699	-0.0698	-20.55%	0.3397	0.3397	0.2475
Mar 27, 2025	0.3396	-0.0229	-6.32%	0.3625	0.3625	0.3267
Mar 26, 2025	0.3744	0.0083	2.27%	0.3661	0.3884	0.3589
Mar 25, 2025	0.3774	0.0021	0.56%	0.3753	0.3986	0.3510
Mar 24, 2025	0.3661	0.0179	5.14%	0.3482	0.3824	0.3364
Mar 21, 2025	0.3528	0.0002	0.06%	0.3526	0.3665	0.3475
Mar 20, 2025	0.3625	0.0150	4.32%	0.3475	0.3862	0.3276
Mar 19, 2025	0.3675	0.0299	8.86%	0.3376	0.3808	0.3326
Mar 18, 2025	0.3401	-0.1051	-23.61%	0.4452	0.4989	0.3290
Mar 17, 2025	0.3973	0.0244	6.54%	0.3729	0.4074	0.3556
Mar 14, 2025	0.3585	-0.0004	-0.11%	0.3589	0.3640	0.3339
Mar 13, 2025	0.3551	-0.0072	-1.99%	0.3623	0.3901	0.3358
Mar 12, 2025	0.3416	-0.0106	-3.01%	0.3522	0.3522	0.3199
Mar 11, 2025	0.3344	0.0048	1.46%	0.3296	0.3475	0.3120
Mar 10, 2025	0.3276	-0.0120	-3.53%	0.3396	0.3396	0.3181
Mar 7, 2025	0.3376	-0.0050	-1.46%	0.3426	0.3444	0.3278
Mar 6, 2025	0.3219	-0.0072	-2.19%	0.3291	0.3365	0.3219

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Genprex, Inc. Company profile

About Genprex Inc

Genprex, Inc. is a clinical-stage gene therapy company focused on developing treatments for cancer and diabetes. The Company's lead cancer drug candidate, REQORSA Immunogene therapy drug (also referred to as GPX-001), is being developed to treat non-small cell lung cancer (NSCLC). The active agent in REQORSA is a TUSC2 gene expressing plasmid that is encapsulated in a DOTAP cholesterol nanoparticle. TUSC2 is a tumor suppressor gene which has both tumor killing (via apoptosis) and immunomodulatory effects. The Company utilizes its ONCOPREX Nanoparticle Delivery System to deliver the TUSC2 gene expressing plasmid to cancer cells. Its diabetes gene therapy, also referred to as GPX-002, is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body's immune system.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Genprex Inc revenues was not reported. Net loss increased 9% to $13.9M. Higher net loss reflects General and administrative increase of 13% to $8.8M (expense), Research and development increase of 3% to $5.1M (expense), Interest Income decrease of 76% to $4K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.39 to -$0.30.

Industry:

Bio Therapeutic Drugs

1601 Trinity Street, Bldg. B
Suite 3.322
AUSTIN
TEXAS 78712
US